Gonadorelin

Quick Facts

Property	Value
Category	GnRH Peptide
Risk Level	Moderate
Administration	Subcutaneous Injection
Typical Frequency	Twice Weekly
Estimated Half-Life	Very Short Plasma Half-Life
Primary Research Interest	LH/FSH Signaling / Fertility / Testosterone Support

Important Disclaimer

This material is provided strictly for educational and informational purposes related to peptide research and endocrine signaling compounds. Gonadorelin is a biologically active GnRH peptide capable of significantly altering hormonal signaling involving LH, FSH, testosterone, and fertility pathways. Information presented here should not be interpreted as medical advice, treatment recommendations, or encouragement of unsupervised use.

1. Reconstitution Guide

Vial Size: 5 mg
Dilutant Type: BAC Water
Amount of Dilutant Added: 2.5 mL
Final Concentration: 2.00 mg/mL

At this concentration:

• 100 mcg = 0.050 mL (5.0 units)

• 250 mcg = 0.125 mL (12.5 units)

• 500 mcg = 0.250 mL (25.0 units)

2. Route of Administration

Gonadorelin is most commonly administered as a subcutaneous injectable GnRH peptide.

Primary Route: SubQ Injection
Preferred Timing: Flexible timing depending on protocol goals
Administration Notes: Often used intermittently to support endogenous LH and FSH signaling

3. Typical Research Protocols

Product Strength: 2.00 mg/mL
Typical Delivered Amount: 500 mcg
Frequency: Twice weekly
Cycle Length: 12 weeks on / 4 weeks off
Special Notes: Several different Gonadorelin protocols are commonly discussed. Popular approaches include 100 mcg daily, 250 mcg 2–3 times weekly, or 500 mcg twice weekly depending on research goals and tolerance.

4. Summary

Gonadorelin is a synthetic form of gonadotropin-releasing hormone (GnRH) researched for its ability to stimulate luteinizing hormone (LH) and follicle-stimulating hormone (FSH) production.

Research interest in Gonadorelin commonly centers around testosterone support, fertility signaling, hypothalamic-pituitary-gonadal axis function, and endocrine recovery applications.

5. Mechanism of Action

Gonadorelin functions by stimulating GnRH receptors within the pituitary gland, promoting downstream release of LH and FSH.

LH stimulation
FSH stimulation
Testosterone production signaling
Fertility pathway activation
Hypothalamic-pituitary-gonadal axis modulation

The compound is often researched as an alternative strategy to directly stimulating the testes with hCG.

6. Potential Benefits

Potential endogenous testosterone support
Possible fertility support signaling
Maintenance of LH and FSH activity
Potential endocrine recovery support
Possible testicular function support

7. Potential Risks / Side Effects

Moderate

Headaches
Nausea
Flushing
Hormonal instability
Mood changes
Potential receptor desensitization with excessive use
Endocrine disruption if improperly cycled

8. Half-Life

Gonadorelin is commonly discussed as having a very short circulating plasma half-life measured in minutes.

Despite this short duration, downstream hormonal signaling effects may persist considerably longer.

9. Storage Information

Store refrigerated before and after reconstitution
Protect from direct light exposure
Avoid repeated freeze-thaw cycles
Maintain sterile handling practices during preparation

10. Contraindications / Warnings

Hormone-sensitive cancers
Pregnancy or breastfeeding
Severe endocrine disorders
Known hypersensitivity to peptide compounds
Use alongside other hormonal manipulation compounds without supervision

11. Research References

PubMed
NIH Publications
Endocrinology literature
Peer-reviewed fertility and hormone journals